Portfolio company
Miist Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Misti
Misti develops customisable nebuliser technology to deliver medicines to the lungs of children and older adults with respiratory diseases.
Salvia
The company develops minimally invasive, ultra-thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraines.
Softhale
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
eNeura
This company develops portable transcranial magnetic stimulation devices for patients to treat and prevent migraine symptoms.
Salvia BioElectronics
This company develops thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraine and other neurological conditions.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Kinaset Therapeutics
This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.
Breath Therapeutics
This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.
